HeartWare International Expands Intellectual Property And Technology Portfolio Through Definitive Agreement To Acquire World Heart Corporation For US$8 Million

Additional Information and Where You Can Find It

HeartWare will file a Registration Statement on Form S-4 containing a proxy statement/prospectus and other documents concerning the proposed acquisition and WorldHeart will file a proxy statement and other documents concerning the acquisition, in each case with the Securities and Exchange Commission (the "SEC").  Investors are urged to read the proxy statement/prospectus when it becomes available and other relevant documents filed with the SEC because they will contain important information.  Security holders may obtain a free copy of the proxy statement/prospectus (when it is available) and other documents filed by HeartWare and WorldHeart with the SEC at the SEC's web site at http://www.sec.gov.  The proxy statement/prospectus and other documents may also be obtained for free by contacting HeartWare Investor Relations by e-mail at [e-mail] or by telephone at 781.739.0864 or by contacting WorldHeart Investor Relations by e-mail at [e-mail] or by telephone at 801.355.6255.



HeartWare, WorldHeart and their respective directors, executive officers, certain members of management and certain employees may be deemed to be participants in the solicitation of proxies in connection with the proposed merger.  A description of the interests in HeartWare of its directors and executive officers is set forth in HeartWare's statement for its 2011 Annual Meeting of Shareholders, which was filed with the SEC on April 8, 2011.  This document is available free of charge at the SEC's web site at www.sec.gov or by going to HeartWare's Investors page on its corporate web site at www.heartware.com.  Information concerning WorldHeart's directors and executive officers is set forth in WorldHeart's proxy statement for its 2011 Annual Meeting of Shareholders, which was filed with the SEC on May 2, 2011.  This document is available free of charge at the SEC's web site at www.sec.gov or by going to WorldHeart's Investors page on its corporate web site at www.worldheart.com.  Additional information regarding the persons who may, under the rules of the SEC, be deemed participants in the solicitation of proxies in connection with the proposed merger, and a description of their direct and indirect interests in the proposed merger, which may differ from the interests of HeartWare stockholders or WorldHeart shareholders, generally will be set forth in the proxy statement/prospectus when it is filed with the SEC.

« First ‹ Previous 1 2 3 4 Next › Last »